[Use of prostaglandin E1 for treatment of erectile dysfunction].
Recently there has been observed a significant increase in frequency of erectile dysfunction in Poland. Contemporary methods of the therapy of this disturbance are based not only on psychotherapy, oral drugs and other non invasive methodes, but on intracavernous injection of vasodilatory agents as well. The objective of the study was to evaluate the efficiency of intracavernous quick self-injection of prostaglandin E1 implementing automatic "SELFINJECT" device. Authors achieved 93% of positive results. That method seems to be safe and well tolerated.
Milewczyk
P
P
II Katedry i Kliniki Połoznictwa i Ginekologii Akademii Medycznej w Warszawie.
Marcyniak
M
M
Maj
K
K
el-Rabti
A M
AM
D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage*; D004333:Drug Administration Routes; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D012646:Self Administration; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage*
D014665:Vasodilator Agents; D000527:Alprostadil